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DOI: 10.1039/b804935aInductively coupled plasma dynamic reaction cell-quadrupole mass spectrometry (ICP-DRC-qMS)
coupled on-line with anion exchange chromatography (AEC) has been developed for the quantification
of selenium-tagged proteins in human plasma. Methane was employed as a reaction gas in the dynamic
reaction cell to achieve the determination of 80Se free of spectroscopic interference from 40Ar2
+ and
79BrH+. Five selenium species including selenoprotein P (SelP), glutathione peroxidase (GPx),
selenoalbumin (SeAlb), and two unknown selenospecies (U1 and U2) in a pooled plasma sample from
five healthy people were separated using AEC, and the distribution of selenium in SelP, GPx, SeAlb,
U1 and U2 (about 45.5%, 19.1%, 15.1%, 2.9% and 8.1%) was determined by ICP-DRC-qMS using
species-unspecific isotope dilution (80Se/77Se). Based on the detection limit (DL) of selenium
(0.54 ng mL1), we estimated that the DLs for SelP and GPx were 0.59 pmol mL1 and 1.7 pmol mL1,
respectively. Through the stoichiometry of the selenium atom in the selenium-tagged proteins, SelP
(2.7  0.1 mg mL1) and GPx (5.4  0.2 mg mL1) were successfully quantified.Introduction
Selenium, an essential trace element with important biochemical
functions when it is in a reasonable concentration range, plays
a key role in human health, while its deficiency or overabundance
causes disease.1,2 In the past few decades, about 25 selenoproteins
have been identified which are distributed in different tissues in
the human body.3,4 Among these, three selenium-tagged
proteins, namely selenoprotein P (SelP), glutathione peroxidase
(GPx) and selenoalbumin (SeAlb), have been identified in human
plasma so far.5 SelP and GPx belong to selenoproteins in which
the selenium is incorporated as selenocysteine while SeAlb is
a nonspecific selenium-containing protein in which selenium is
incorporated as selenomethionine in place of methionine.
Compared with using the total selenium concentration or GPx
activity in human blood plasma and/or serum to evaluate the
selenium status in the body, the quantitative concentrations of
specific selenium-tagged proteins provide more significant
information concerning physiological changes and the relation-
ship between the level of specific selenium-tagged proteins and
diseases.6,7 However, quantification of selenium-tagged proteins
in human plasma is sometimes difficult and a time-consuming
process and, therefore, still remains a challenge in physiological
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This journal is ª The Royal Society of Chemistry 2008Although ICPMS has been widely used in the analysis of
selenoprotiens, it suffers spectroscopic interference from
polyatomic ions formed by the presence of argon and the sample
matrix.8 For example, determination of the major selenium
isotope (80Se) is hampered by the spectroscopic interference
originating from the 40Ar2
+ dimmer and 79BrH+. To eliminate this
spectroscopic interference, methane was employed in the
dynamic reaction cell (DRC) for realizing accurate quantification
of selenium.8–10
In the articles published about analysis of selenoproteins in
human plasma and/or serum, size exclusion chromatography
(SEC), affinity chromatography (AC) and anion exchange
chromatography (AEC) are frequently used.11–16 However, SEC
cannot provide precise quantitative results for selenoproteins
because its poor resolving power results in overlap between
high abundance selenium-containing proteins (SeAlb) and
selenoproteins.15 In AC, the non-retained target selenoprotein
(GPx) is eluted together with the unwanted matrix, causing
difficulties for the accurate quantification of selenium in the
GPx.14 Compared with the former two chromatographic
methods, AEC is more suitable for separating selenoproteins
because the surface charge of different selenoprotein molecules is
discrepant under a certain pH condition. Based on the principle
of ion exchange in AEC, different kinds of selenoprotein could be
separated.14 Unfortunately, previous attempts of separating
selenoproteins by AEC were not fully satisfied. Recently, the
principle of anion exchange was applied in the analysis of sele-
noproteins combined with AC to alleviate the spectral interfer-
ences of Cl and Br, making it possible to use a conventional
ICPMS without DRC and/or a collision cell (CC).17,18 Relative to
the somewhat complicated on-line and off-line procedures which
need sophisticated design and skillful technicians, a simpler and





























































View OnlineIn this study, a novel AEC/ICP-DRC-qMS was developed so
as to allow effective separation of SelP, GPx and SeAlb in
a single run, and determination of the most abundant selenium
isotope 80Se without the possible polyatomic interference.
Post-column species-unspecific isotope dilution analysis was
employed for quantifying the amount of selenium in seleno- and
selenium-containing proteins. Finally, the newly established
method was applied to quantification of selenoproteins in
a pooled human plasma sample of five healthy people.
Experimental
Apparatus
Chromatographic separations were carried out on a SERIES
200 HPLC system (PerkinElmer, SCIEX, Canada). An anion
exchange column (ProPac SAX-10, 2.0 I.D.  250 mm in length,
10 mm particle size, Dionex, Sunnyvale, USA) was used to
separate the selenium species in human plasma. The effluent
from the column was mixed with the enriched 77Se spike solution
continuously pumped by a syringe pump (Cole-Parmer, East
Bunker Court Vernon Hills, USA) through a three-way
connector for on-line determination using an ELAN DRC II
ICPMS (PerkinElmer, SCIEX, Canada) equipped with
a concentric pneumatic nebulizer and a Cyclonic spray chamber.
Size exclusion chromatography was performed with a ZORBAX
Bio Series GF-250 column (Agilent Technologies, UK). To
obtain the best sensitivity, parameters such as lens voltage and
nebulizer gas flow were optimized daily. Deadtime of the detector
caused by high count rates was corrected using a Deadtime
Correction function in the software. The CH4 (99.999%) and O2
(99.999%) used as reaction gases were purchased from the Beijing
AP Beifen Gases Industry Co. (Beijing, China). To analysis
the total selenium content in human plasma, steel liner PTFE
pressure digestion vessels were used to digest the human plasma
samples.
Reagents and materials
All reagents used were at least of analytical-reagent or
high-purity grade in this study. A stock standard solution of
1007 mg mL1 of Se stabilized in 2.2% (v/v) nitric acid for ICPMS
was purchased from Sigma–Aldrich (Saint Louis, Missouri,
USA). Seleno-DL-methionine, seleno-DL-cystine, GPx from
bovine erythrocytes, and albumin from human serum were also
purchased from Sigma–Aldrich. Sodium selenite and sodium
selenate were purchased from Beijing Chemical Reagent Co. Ltd.
(Beijing, China). For the purification of SelP, heparin-sepharose
CL-6B (Pharmacia, Uppsala, Sweden) was used. Tris-(hydrox-
ymethyl) aminomethane and ammonium acetate (Sinopharm
Chemical Reagent Co. Ltd., Shanghai, China) were used to
prepare the mobile phase. Mobile phase and other solutions were
all prepared with ultra-pure water (18.2 MU cm, Pen-Tung Sah
Micro-Electro-Mechanical Systems Research Center of Xiamen
University, China).
The enriched isotopic spike solution of 77Se was prepared by
dissolving approximately 2 mg enriched 77Se powder (99.66%,
Cambridge Isotope Laboratories, Inc., USA) in high-purity
grade nitric acid. Then the solution was diluted to 100 mL with
ultra-pure water as a stock solution. The exact concentration of1546 | J. Anal. At. Spectrom., 2008, 23, 1545–1549the spike solution (2.66 mg mL1) was determined by reverse
isotope dilution analysis.
Human plasma samples from healthy persons were purchased
from Xiamen Blood Center as fresh frozen plasma. All plasma
samples were stored at 20 C until analysis.
Procedures
Purification of selenoprotein P by affinity chromatography.
Because SelP was not commercially available, it was purified
from human plasma using affinity chromatography as described
previously.11,19 Briefly, 10 mL plasma was diluted with an equal
volume of 10 mM Na2HPO4 + 150 mM NaCl buffer (pH ¼ 7.4)
and applied to a glass column (1.0 I.D.  20 cm in length) packed
with 3 g of heparin-sepharose CL-6B. After being equilibrated
with 30 mL 10 mM Na2HPO4 + 150 mM NaCl buffer on
a Shimadzu LC-10ADVP HPLC (Kyoto, Japan) equipped with
a SPD-M10A detector, SelP on the column was eluted at a flow
rate of 1.0 mL min1 by 20 mM Tris + 800 mM NH4Ac buffer
(pH ¼ 7.4) and collected under 280 nm monitoring. It was
confirmed using SDS-PAGE and ICP-DRC-qMS (Fig. S1 and
S2†) and stored at 20 C before use.
Anion exchange chromatography of selenium species. The
chromatographic conditions were optimized for separating seven
standard selenium species, namely SelP, GPx, albumin, (SeCys)2,
SeMet, SeO3
2 and SeO4
2, and these are summarized in Table 1.
Before sample loading, the column was first equilibrated for
30 min with mobile phase A and then a 35 min gradient elution
program (Table 1) was used for separating these species. For real
sample analysis, plasma samples were just filtered using
a 0.45 mm syringe filter, avoiding the loss of selenium species.
Isotope dilution analysis of selenium in human plasma. To
quantify the selenium-tagged proteins in human plasma using
post-column species-unspecific isotope dilution, an enriched 77Se
spike solution was mixed continuously into the chromato-
graphic effluent to change the isotope ratio of 80Se/77Se. In order
to keep the flow stable and mixed sufficiently, a flow rate of
20 mL h1 was adjusted using an accurate syringe pump. The
signals of 77Se, 78Se, 80Se, 82Se were monitored when CH4 was
used as a reaction gas and the signal of 32S16O was monitored
for sulfur determination when O2 was used. In order to compare
the quantity of different selenium species with the total selenium
content, a 500 mL aliquot of human plasma and another aliquot
spiked with 15 mL enriched 77Se solution were added, respec-
tively, into pressure digestion vessel systems together with 2 mL
high-purity grade nitric acid. The digestion vessels were heated
at 170 C for 10 h. After cooling, the digests were each diluted
to 10 mL with ultra-pure water, and the isotope ratio of
80Se/77Se was measured using ICP-DRC-qMS to obtain the total
selenium content.
Results and discussion
Optimization of DRC operating conditions
So far, many reaction gases have been tried in the DRC for
reducing spectroscopic interference. In terms of selenium quan-
tification, CH4 is more effective in eliminating the interferenceThis journal is ª The Royal Society of Chemistry 2008
Table 1 Operating conditions for AEC/ICP-DRC-qMS
AEC parameters
Anion exchange column ProPac SAX-10 (250  2 mm I.D., 10 mm)
Sample volume 200 mL
Mobile phase Eluent A: 10 mM Tris-HAc buffer, pH ¼ 8.0
Eluent B: A + 500 mM ammonium acetate, pH ¼ 8.0
Gradient program 0–3 min 100% eluent A
3–10 min 100–60% eluent A
0–40% eluent B
10–16 min 60–0% eluent A
40–100% eluent B
16–35 min 100% eluent B
Flow rate 0.25 mL min 1
ICP-DRC-qMS parameters




Reaction gas flow rate 0.7 mL min 1,a 0.4 mL min1b
Rejection parameter q 0.45,a 0.35b
a CH4 used as a reaction gas for






























































View Onlinethan NH3, H2 and O2 as described in a previous work.
9 A
standard selenium solution of 10 ng mL1 was used here for
optimizing the DRC conditions. The main optimized parameters
of the DRC were the flow rate of CH4 and the value of the
rejection parameter q (Rpq). Results indicated that the ratio of
signal to noise for 80Se is at a maximum when Rpq ¼ 0.45 and
VCH4 ¼ 0.7 mL min1 (Fig. S3).† Sulfur determination was
achieved by introducing O2 into the DRC to form
32S16O+ instead
of monitoring 32S+, thus eliminating the interference of 16O16O+,
and Rpq ¼ 0.35 and VO2 ¼ 0.4 mL min1 were chosen for sulfur
determination in this study.Fig. 1 Comparison of chromatogram (a) standard selenium species with
(b) selenium species in healthy human plasma. Peak in chromatogram
(b): (1) SelP, (2) GPx, (3) SeAlb, (4) U1, (5) U2. All the selenium species
were monitored by 80Se except albumin monitored by 32S16O. Detailed
conditions were listed in Table 1.Separation of selenium species by anion exchange
chromatography
For an effective separation of selenium species including SelP,
GPx, albumin and (SeCys)2, SeMet, as well as SeO3
2 and SeO4
2
(5 ng mL1 as Se each), pH and ionic strength gradient elution
should be considered and applied as well as a suitable selection of
column. Among these selenium species, only SelP interacts
weakly with the stationary phase of the column. In order to
strengthen SelP to retain in the column, the pH of the mobile
phase was adjusted to 8.0 to ensure its elution (retention time,
2.4 min) after the deadtime (<2.0 min) as shown in Fig. 1.
Because a high pH value makes a protein molecule’s surface
more negatively charged, it enhances its interaction with the
stationary phase.
During the process of chromatographic separation, the
isotopes of 77Se, 78Se, 80Se and 82Se were monitored simulta-
neously on-line with ICP-DRC-qMS to ensure no isobaric
interference existed. All the standard selenium species were
detected with 80Se except albumin, because the content of
selenium in this economic product is too little (Fig. S4).† The
albumin used was probably produced by recombinant tech-
nology in a low-selenium environment. Thus, 32S16O+ was
monitored when albumin was analyzed, and a shoulder peak was
observed probably caused by the co-existence of different
molecular configurations in the standard.This journal is ª The Royal Society of Chemistry 2008Quantification of selenium-tagged proteins in human plasma
Although species-specific isotope dilution (SSID) can provide the
most credible data,20 species-unspecific isotope dilution (SUID)
is more universal for analysis of all species known and unknown
because the limited availability of isotopically labeled
compounds impedes the application of SSID. For SUID, the
compound used as the spike solution does not need to be the
same as the target analyte in the sample based on the knowledge
that all species are broken and ionized into atoms and ions in
ICP. 80Se and 77Se were detected during the quantification of
selenium species by AEC/ICP-DRC-qMS, and the detailed
quantitative calculation process for the amount of selenium was
described previously.21–23
Comparing with using H2 as a collision gas in CC or anion
exchange solid phase extraction unit before AC and/or AEC for





























































View Online40Ar40Ar and 1H79Br to 80Se as well as 40Ar37Cl to 77Se to achieve
accurate quantification of selenoproteins,14,17,18 separation of all
Se species in a single AEC run coupled on-line with ICP-DRC-
MS detection using CH4 as a reaction gas is more attractive. In
this case, no obvious interference was observed by monitoring
multi-isotopes of selenium, suggesting that the spectral interfer-
ences from 40Ar37Cl, 1H79Br and 40Ar40Ar could be eliminated by
both AEC separation and CH4-based DRC.
Plasma has been reported to give higher background signals
owing to its more complex matrix than serum in AAS, but they
produced similar distribution patterns of selenium-tagged
proteins.11 A pooled fresh plasma sample of five healthy people
was analyzed for quantification of selenium-tagged proteins
in this study. Fig. 2 shows the quantitative chromatogram of
selenium species in the plasma by SUID AEC/ICP-DRC-qMS
using a modified chromatographic condition to obtain better
peak shape and ensure the elution of SelP beyond the void of the
column. One can see that the signal of 77Se in Fig. 2a increased
along with the gradient and its intensity was enhanced about
3 times, suggesting that increasing the concentration of NH4Ac
in the mobile phase resulted in the enhancement of selenium
sensitivity. However, the exact principle is not yet clear. It has
been suggested that, during ICP, the addition of volatile carbon
compounds would enhance the efficiency of element ionization,
which have lower ionization potential than carbon.24,25 An
unexpected benefit of this phenomenon makes it possible to
detect trace selenium species such as U1 and U2 as shown inFig. 2 (a) Chromatogram of selenium species in healthy human plasma
obtained using species-unspecific isotope dilution AEC/ICP-DRC-qMS.
(b) Isotope ratio (Rm) chromatogram of
80Se/77Se after being corrected for
mass bias. Detailed conditions are the same as those in Fig. 1 except that
the pH of mobile phase A was modified to be 8.6.
Table 2 Quantitative analysis of selenium-tagged proteins in human plasma
Selenium speciesa SelP GPx
Retention time/min 2.38 15.48
Molecule weight/kDa 50.526 95.027
Se concentration/ng mL1 42.85  2.11 18.01  0.
Se percentage (%) 45.5 19.1
Protein concentration/mg mL1 2.7  0.1 5.4  0.2
a Mean  SD (n ¼ 3). b Producer’s information.
1548 | J. Anal. At. Spectrom., 2008, 23, 1545–1549Fig. 2. Moreover, the change of the isotopic signal intensity
would not affect accurate quantification because the value of Rm
would be independent of the efficiency of ionization. Following,
we collected the fraction of U1 and U2 to analyze them by SEC/
ICP-DRC-qMS (Fig. S5).† The result shows their molecule
weights are much less than 18 kDa.
The concentrations of selenium in SelP, GPx and SeAlb in
the pooled plasma sample were 42.85  2.11, 18.01  0.70 and
14.26  0.13 ng mL1, respectively, which are basically coinci-
dent with previously reported results.11,14–16 Selenium distribu-
tion was determined to be 45.5% in SelP, 19.1% in GPx, 15.1% in
SeAlb, 2.9% in U1 and 8.1% in U2 based on the amount of total
selenium in the plasma (94.24  1.48 ng mL1). The sum of the
selenium quantified for each selenium species amounts for 91%
of the total Se in plasma. We guess the loss is mainly caused by
the reservation of the column under high pH of the mobile phase.
From the selenium concentration determined in the selenium-
tagged proteins, it is possible to obtain the content of SelP and
GPx in the plasma through stoichiometry of the selenium in the
molecules, since there are ten selenium atoms in each SelP mole-
cule and four in GPx (structured by 4 subunits).3,27 The results
obtained indicate that most of the selenium in the plasma is
stored in SelP, although the abundance of this protein (2.7 
0.1 mg mL1) is less than GPx (5.4  0.2 mg mL1) and SeAlb
(a high-abundance protein in plasma15) (Table 2), suggesting that
SelP might become a biomarker indicating the status of selenium
nutrition. Based on the DL of selenium (0.54 ng mL1), we esti-
mated that the DLs for SelP and GPx should be 0.59 pmol mL1
and 1.7 pmol mL1, respectively. The concentration of SeAlb was
estimated to be less than 12.0  0.1 mg mL1 based on the fact that
there is at least one selenium atom in each SeAlb molecule. It is not
possible to provide the exact value here due to the fact that
selenomethionine was incorporated nonspecifically into albumin
in place of methionine forming SeAlb.Conclusions
The SUID AEC/ICP-DRC-qMS method developed here
demonstrated the feasibility of selenium-tagged protein quanti-
fication in human plasma through the determination of selenium
in the protein molecules, and offered a simple alternative for
selenium speciation analysis. This heteroatom (such as selenium
in this study)-tagged strategy is expected to be useful, after
suitable modification, in moving qualitative proteomics towards
quantitative proteomics, as long as the information of the
heteroatom stoichiometry in the peptide and/or protein molecule
is known and quantitative separation of the peptides and
proteins can be achieved.SeAlb U1 U2
21.32 24.40 29.81
66.4b — —
70 14.26  0.13 2.77  0.06 7.60  0.23
15.1 2.9 8.1
<12.0  0.1 — —
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